Saratoga Research & Investment Management Biogen Inc. Transaction History

Saratoga Research & Investment Management

$2.2 Billion
Q2 2024

A detailed history of Saratoga Research & Investment Management transactions in Biogen Inc. stock. As of the latest transaction made, Saratoga Research & Investment Management holds 157,791 shares of BIIB stock, worth $31.8 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

157,791

Previous 162,851 3.11%

Holding current value

$31.8 Million

Previous $35.1 Million 4.17%

% of portfolio

1.66%

Previous 1.6%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	SELL	$190.52 - $236.72 $964,031 - $1.2 Million	-5,060 Reduced 3.11%	157,791 $36.6 Million
Q1 2024 Apr 17, 2024	SELL	$212.02 - $267.71 $291,527 - $368,101	-1,375 Reduced 0.84%	162,851 $35.1 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $2.64 Million - $3.17 Million	-11,838 Reduced 6.72%	164,226 $42.5 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $754,580 - $851,666	-2,979 Reduced 1.66%	176,064 $45.3 Million
Q2 2023 Jul 24, 2023	SELL	$275.25 - $318.06 $1.18 Million - $1.36 Million	-4,286 Reduced 2.34%	179,043 $51 Million
Q1 2023 May 05, 2023	SELL	$256.56 - $292.34 $184,723 - $210,484	-720 Reduced 0.39%	183,329 $51 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $12 Million - $14.5 Million	-47,356 Reduced 20.46%	184,049 $51 Million
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $207,344 - $285,909	-1,065 Reduced 0.46%	231,405 $61.8 Million
Q2 2022 Aug 01, 2022	SELL	$187.54 - $223.02 $1.5 Million - $1.78 Million	-7,978 Reduced 3.32%	232,470 $47.4 Million
Q1 2022 Apr 29, 2022	BUY	$193.77 - $244.14 $1.02 Million - $1.28 Million	5,257 Added 2.24%	240,448 $50.6 Million
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $1.15 Million - $1.48 Million	-5,133 Reduced 2.14%	235,191 $56.4 Million
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $206,299 - $269,037	-729 Reduced 0.3%	240,324 $68 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $3.4 Million - $5.44 Million	-13,128 Reduced 5.16%	241,053 $83.5 Million
Q1 2021 Apr 12, 2021	BUY	$242.95 - $284.63 $1.82 Million - $2.13 Million	7,481 Added 3.03%	254,181 $71.1 Million
Q4 2020 Feb 03, 2021	BUY	$236.26 - $355.63 $1.8 Million - $2.71 Million	7,625 Added 3.19%	246,700 $60.4 Million
Q3 2020 Oct 09, 2020	SELL	$264.77 - $305.71 $1.06 Million - $1.23 Million	-4,021 Reduced 1.65%	239,075 $67.8 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $735,111 - $973,527	-2,842 Reduced 1.16%	243,096 $65 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $677,233 - $859,079	2,519 Added 1.03%	245,938 $77.8 Million
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $280,356 - $387,385	1,274 Added 0.53%	243,419 $72.2 Million
Q3 2019 Oct 29, 2019	BUY	$217.44 - $243.88 $469,235 - $526,293	2,158 Added 0.9%	242,145 $56.4 Million
Q2 2019 Jul 24, 2019	BUY	$219.29 - $241.72 $17.4 Million - $19.2 Million	79,307 Added 49.36%	239,987 $56.1 Million
Q1 2019 Apr 18, 2019	BUY	$216.71 - $338.96 $3.2 Million - $5.01 Million	14,774 Added 10.13%	160,680 $38 Million
Q4 2018 Jan 15, 2019	SELL	$278.5 - $352.75 $2.46 Million - $3.11 Million	-8,821 Reduced 5.7%	145,906 $43.9 Million
Q3 2018 Oct 15, 2018	SELL	$293.51 - $383.83 $1.54 Million - $2.01 Million	-5,246 Reduced 3.28%	154,727 $54.7 Million
Q2 2018 Jul 17, 2018	SELL	$257.52 - $306.91 $57,941 - $69,054	-225 Reduced 0.14%	159,973 $46.4 Million
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $3.76 Million - $5.31 Million	14,439 Added 9.91%	160,198 $43.9 Million
Q4 2017 Jan 19, 2018	BUY	$307.64 - $344.58 $1.31 Million - $1.46 Million	4,250 Added 3.0%	145,759 $46.4 Million
Q3 2017 Oct 24, 2017	BUY	$281.15 - $329.69 $39.8 Million - $46.7 Million	141,509	141,509 $44.3 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saratoga Research & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Saratoga Research & Investment Management with notifications on news.

Account

Saratoga Research & Investment Management Biogen Inc. Transaction History